Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca to present scientific advances in cardiovascular and metabolic diseases at 2017 ADA Scientific Sessions
-
AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig
-
Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer
-
AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee
-
AstraZeneca delivers new data on expanding portfolio of cancer medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Bydureon EXSCEL trial meets primary safety objective in type-2 diabetes patients at wide range of cardiovascular risk
-
Phase III ZONDA trial for benralizumab shows ability to reduce oral steroid use in severe asthma patients
-
AstraZeneca enters agreement with Recordati for Seloken in Europe
-
Brodalumab receives positive CHMP opinion for the treatment of adult patients with moderate-to-severe plaque psoriasis
-
AstraZeneca to present scientific advancements from growing respiratory portfolio at the American Thoracic Society conference 2017
Latest articles and press releases
All of our latest press releases and articles are available to explore
